Past failures pave way for promising new Alzheimer's treatments
2015-06-03
(Press-News.org) Since 2002, close to 300 drug candidates to treat Alzheimer's have run into clinical dead ends. But now, having learned from those failures, researchers are testing -- and retesting -- a batch of the most promising compounds designed to slow the disease's progression. An article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, describes what made this possible and what lies ahead.
Lisa M. Jarvis, a senior correspondent at C&EN, reports that just a few years ago, Alzheimer's research suffered from several high-profile setbacks. Experimental therapies, many of which targeted amyloid-? peptides, failed in clinical trials. The string of disappointments added to the already-existing doubt over whether amyloid-? was causing the disease. But researchers would later acknowledge that the clinical trials -- and in some cases, drugs themselves -- were fundamentally flawed.
Now equipped with better technologies and a better understanding of how the disease unfolds, several pharmaceutical companies are leading clinical trials to test new Alzheimer's drug candidates that target either amyloid-? or tau, a protein also implicated in the condition. So far, early results are promising for patients with mild symptoms of the disease. Although the therapies don't represent a cure, they signal long-awaited progress.
INFORMATION:
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter Facebook
ELSE PRESS RELEASES FROM THIS DATE:
2015-06-03
To visualize cancer throughout the body, physicians often turn to positron emission tomography (PET), which lights up areas that are metabolically active or growing, like tumors. Today in ACS Central Science, researchers report development of new PET probes composed of labeled antibody fragments that were tested in mice. These probes could someday be used to create targeted probes, giving doctors more information about tumors and how to treat them.
The most common PET imaging probe is a labeled sugar molecule called 18F-2-deoxyfluoroglucose (FDG). PET indicates those ...
2015-06-03
Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.
The paper, which was published today in the international peer-reviewed journal Obesity Reviews, recommends women with obesity should lose weight before they become pregnant, and also highlights the current lack of support available ...
2015-06-03
Life without bright screens on our smart phones and TVs is hard to imagine. But in 20 years, one of the essential components of the liquid-crystal displays, or LCDs, that make many of our gadgets possible could disappear. To address the potential shortage of this component -- the element indium -- scientists report in the journal ACS Sustainable Chemistry & Engineering a new way to recover the valuable metal so it could be recycled.
Many consumer electronics from laptops to tablets contain thin films of indium tin-oxide that act as transparent conductive coatings in ...
2015-06-03
Montreal, June 3, 2015 -- For many, summer holidays mean hitting the highway -- but nothing puts a damper on a road trip like an accidental collision with a deer.
For Jochen Jaeger, a professor in Concordia University's Department of Geography, Planning and Environment, improving roadkill prevention is best approached through experimentation.
In a study recently published in the Journal of Environmental Management, Jaeger and a group of co-authors from international universities show that protecting animals from speeding vehicles doesn't have a one-size-fits-all solution. ...
2015-06-03
Decentralized partially observable Markov decision processes are a way to model autonomous robots' behavior in circumstances where neither their communication with each other nor their judgments about the outside world are perfect.
The problem with Dec-POMDPs (as they're abbreviated) is that they're as complicated as their name. They provide the most rigorous mathematical models of multiagent systems -- not just robots, but any autonomous networked devices --under uncertainty. But for all but the simplest cases, they've been prohibitively time-consuming to solve.
Last ...
2015-06-03
The first feeding study of tropical Australia's Irukandji box jellyfish has found that they actively fish. They attract larval fish by twitching their extended tentacles, highlighting their nematocyst clusters (stinging structures) and using them as lures.
It's an impressive feat by any standards, but particularly so for an animal that doesn't have a defined brain.
The laboratory-based study of Carukia barnesi, the tiny but deadly Irukandji jellyfish, was conducted at James Cook University (JCU) in Cairns, Australia, and has been published in the online journal PLOS ONE. ...
2015-06-03
WASHINGTON - Contrary to popular belief, cyberbullying that starts and stays online is no more emotionally harmful to youngsters than harassment that only occurs in-person and may actually be less disturbing because it's likelier to be of shorter duration and not involve significant power imbalances, according to a study published by the American Psychological Association.
Researchers at the University of New Hampshire analyzed data from the Technology Harassment Victimization Study, funded by the National Institute of Justice. They focused on telephone interviews conducted ...
2015-06-03
Blood clots often form when lipid-rich plaques on the inner surface of arteries rupture and platelets aggregate at the site of injury. Cardiologists from Ludwig-Maximilians-Universitaet (LMU) in Munich have now compared the effects of two new platelet aggregation inhibitors.
Blood clots that form in arteries - so-called arterial thrombosis -are among the most common causes of heart attack and stroke. They are particularly prone to develop when 'atherosclerotic plaques', fatty deposits that build up within the inner lining of major arteries, fracture and break. Circulating ...
2015-06-03
Published in the Journal of the American Society of Nephrology, the treatment, which involves targeting tiny blood and lymphatic vessels inside the kidneys, is shown to improve renal function and slow progression of disease in mice.
Polycystic kidney disease (PKD) is a genetic disorder where fluid filled cysts grow in kidneys and destroy normal renal tissue. It is the world's most common inherited kidney disease, affecting between 1 in 400 and 1 in 1000 people worldwide - around 12.5 million individuals. A rarer form of the disease, which occurs in about one in every ...
2015-06-03
The hippocampus plays a crucial role in memory formation. However, it is not yet fully understood in what way that brain structure's individual regions are involved in the formation of memories. Neuroscientists at the Collaborative Research Center 874 at RUB have recreated this process with the aid of computer simulations. Their findings challenge the model of memory forming in the hippocampus established to date. Their results have been published in the journal PLOS Computational Biology.
Unique anatomy of the hippocampus
The hippocampus' importance for memory forming ...
LAST 30 PRESS RELEASES:
[Press-News.org] Past failures pave way for promising new Alzheimer's treatments
